NASDAQ OMX

Lumenis Unveils the Pulse™ 30H, the State-of-the-Art Laser Solution Designed to Address Any Type and Size of Stone

11.3.2016 09:00 | NASDAQ OMX

Del

YOKNEAM, Israel, 2016-03-11 09:00 CET (GLOBE NEWSWIRE) -- Lumenis Ltd., the world’s largest energy-based medical device company for surgical, aesthetic and ophthalmic applications, announced the launch of Lumenis Pulse 30H, the new addition to Lumenis’ comprehensive Urology portfolio, at the European Association of Urology (EAU) Congress, taking place March 11-15, 2016 in Munich.

A photo accompanying this announcement is available at http://www.globenewswire.com/NewsRoom/AttachmentNg/eebaf25f-74af-4dc8-9177-54732e90b31d

As the newest offering in its category, the Pulse 30H system has an energy per pulse of up to 5J, the highest of its kind, along with a repetition rate of 25Hz. These features contribute to reduced procedure duration, higher stone fragmentation rate and minimal retropulsion. These capabilities set it apart from competition and increase the variety of stone types and sizes addressed during procedures.

“I was extremely impressed by the comprehensive solution the Lumenis Pulse 30H provides in addressing stones of any type and size, as well as tumors,” said Dr. Guido Giusti, Urologist, Head of European Training Center in Endourology, Ospedale San Raffaele-Turro, Milan, Italy. “The system along with its fibers has definitely set a new standard in the mid/low power range of stone systems.”

Offering optimal user experience, the Lumenis Pulse 30H features an intuitive user interface, efficient and flexible space-saving design offered in tower or desktop, green aiming bean in five adjustment options for enhanced endoscopic visibility and a system’s setting summary report for 10 last treatments. Additionally, the Pulse 30H is aligned with Lumenis fibers, maximizing the fiber’s durability and energy utilization during procedures.

“With a history of innovation in the urology community, Lumenis’ holmium lasers and delivery devices are the standard of care in urology. Through our unique Pulse 120H product and the latest additions of Pulse 100H and Pulse 50H, we provide state-of-the-art offerings to various market segments,” said Tzipi Ozer-Armon, CEO of Lumenis. “By adding the Pulse 30H to our family of urology solutions, we are now offering a new best-in-class product in the low-watt segment, and look forward to continuing our commitment to deliver premium products to drive better treatment standards, and ultimately, enhance the quality of care for patients.”

To learn more about the Pulse 30H and Lumenis’ innovative laser technology, please visit the Lumenis booth #E10.

Additionally, Lumenis invites conference attendees to join a holmium panel discussion, “The importance of Holmium High Power / High Repetition to address BPH and stones,” with Professor Olivier Traxer, University of Paris 6th. Panelists will include: Mark Cynk, MD, Spire Turnbridge Wells Hospital; Rick Popert, MD, Guy’s and St. Thomas’ NHS Foundation Trust; Patrick De Geeter,MD, Klinikum Kassel; Tev Aho, MD, Nuffield Health Cambridge Hospital; Mark Leo, MD, Urology Specialists of Nevada; and Guido Giusti, MD, Ospedale San Raffaele-Turro. The panel will be held on Saturday, March 12, 6:00 - 7:30 PM in Room 13B (ICM, Level 1). Instructional courses on the Holmium laser techniques for BPH and stones are provided by Lumenis during EAU. For more information about Lumenis events at EAU, please visit:http://www.lumenis.com/Solutions/Surgical/News/Events/lumenis-at-eau16.

About Lumenis
Lumenis is a global leader in the field of minimally-invasive clinical solutions for the Surgical, Ophthalmology and Aesthetic markets, and is a world-renowned expert in developing and commercializing innovative energy-based technologies, including Laser, Intense Pulsed Light (IPL) and Radio-Frequency (RF). For nearly 50 years, Lumenis' ground-breaking products have redefined medical treatments and have set numerous technological and clinical gold-standards.  Lumenis has successfully created solutions for previously untreatable conditions, as well as designed advanced technologies that have revolutionized existing treatment methods. For more information visit:  www.lumenis.com

         For further information:
         
         Glenn Silver
         Lazar Partners Ltd.
         (646) 871-8495

Om NASDAQ OMX

NASDAQ OMX
NASDAQ OMX
One Liberty Plaza - 165 Broadway
NY 10006 New York

+1 212 401 8700http://www.nasdaqomx.com

NASDAQ OMX (NASDAQ: NDAQ) is a leading provider of trading, exchange technology, information and public company services across six continents.

Følg saker fra NASDAQ OMX

Registrer deg med din epostadresse under for å få de nyeste sakene fra NASDAQ OMX på epost fortløpende. Du kan melde deg av når som helst.

Siste saker fra NASDAQ OMX

Promethean Opens New Global Headquarters in Seattle18.8.2017 18:38Pressemelding

Seattle, Wash., Aug. 18, 2017 (GLOBE NEWSWIRE) -- PrometheanTM, a global education technology company, announced today the opening of its new global headquarters in Seattle, Wash. Promethean's office in Atlanta, Ga. will continue to serve as the hub for the Americas markets, and the Blackburn, U.K. office will continue to carry on as the hub for the EMEA markets and parts of Asia.  Promethean is one of the leading brands in the international education technology market with more than 20 years of experience in the K-12 classroom. Its solutions are in more than 50,000 schools and institutions in 154 countries. "As traditional pedagogy continues to move towards immersive learning, it's important for Promethean to lead innovation in education with the latest technology," said Vin Riera, CEO of Promethean. "Seattle is a global technology hub, and establishing Promethean's global headquarters there increases opportunities for new business models, concepts

Hminers Disrupts the Cryptocurrency Market with Powerful, Multi-Algorithm Mining Rigs18.8.2017 11:00Pressemelding

Hminers continues to hit the headlines in the rapidly expanding global market for cryptocurrency. The Miami-based company has recently introduced three extremely powerful, multi-algorithm mining rigs that have been designed to provide maximum hash rate with minimum power consumption. MIAMI, Aug. 18, 2017 (GLOBE NEWSWIRE) -- In their relentless efforts to deliver state-of-the-art products related to cryptocurrency, Hminers has recently launched three brilliantly designed bitcoin mining rigs. The unique features and capabilities of the company's new H2U Miner, H4U Miner, and Rack Equipped with 5 x H4U have already grabbed the attention of the cryptocurrency enthusiasts and experts around the world. An organization with a rich tradition, Hminers (www.hminers.com) is recognized in the industry as the creator of the first ever 10 nm ASIC Chip in the world. Cryptocurrency mining is the process of generating new cryptocurrency that requires a pot

Nasdaq Welcomes I-AM Capital Acquisition Company (Nasdaq: IAMXU) to The Nasdaq Stock Market17.8.2017 18:50Pressemelding

NEW YORK, Aug. 17, 2017 (GLOBE NEWSWIRE) -- I-AM Capital Acquisition Company (Nasdaq:IAMXU), a blank check company formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses, celebrated its initial public offering (IPO) on The Nasdaq Stock Market.  I-AM Capital's founders, Chief Executive Officer F. Jacob Cherian and Chief Financial Officer Suhel Kanuga, have been focused on investing into India over the last decade, with the distinction of completing the first listed-SPAC investment in India. "Through our keen focus and unique accomplishments in India over the last decade, we have seen our investment thesis bear fruit: India's prominence and rise on the world stage, its distinction as being one of the fastest growing major economies of the world, and its strong vibrant consumer demographics. We believe these factors are aligning well now,

Tetraphase Pharmaceuticals Announces Submission and Validation of IV Eravacycline Marketing Authorization Application by European Medicines Agency17.8.2017 14:30Pressemelding

WATERTOWN, Mass., Aug. 17, 2017 (GLOBE NEWSWIRE) -- Tetraphase Pharmaceuticals, Inc. (NASDAQ:TTPH), a clinical-stage biopharmaceutical company developing novel antibiotics to treat life-threatening multidrug- resistant (MDR) infections, today announced that the Marketing Authorization Application (MAA) for IV eravacycline for the treatment of complicated intra-abdominal infections (cIAI) has been submitted and was validated by the European Medicines Agency (EMA). Eravacycline is a novel, fully-synthetic fluorocycline antibiotic being developed for the treatment of serious infections, including those caused by multidrug-resistant (MDR) pathogens. The MAA filing is based on data from the phase 3 IGNITE1 clinical trial in which eravacycline was well tolerated and demonstrated statistical non-inferiority to ertapenem using the primary endpoint of clinical response at the test-of-cure (TOC) visit. "The MAA filing represents a significant milestone for Tetraphase as it is our

RedHill Biopharma Announces U.S. Commercialization Agreement for FDA-Approved GI Product Esomeprazole Strontium Delayed-Release Capsules17.8.2017 13:00Pressemelding

RedHill was granted the exclusive rights to promote Esomeprazole Strontium Delayed-Release (DR) Capsules to gastroenterologists in certain U.S. territories Esomeprazole Strontium DR Capsules 49.3 mg is an FDA-approved, proprietary, prescription proton pump inhibitor (PPI), indicated for adults for the treatment of gastroesophageal reflux disease (GERD) and other gastrointestinal (GI) conditions   RedHill expects to initiate the U.S. promotion of Esomeprazole Strontium  DR Capsules 49.3 mg  in the coming weeks   Esomeprazole Strontium  DR Capsules 49.3 mg  will be the third commercial GI product to be promoted by RedHill in the U.S.    RedHill's GI-focused sales force currently promotes two GI s

Brand Industrial Services Announces Agreement to Acquire Venko Groep BV16.8.2017 19:40Pressemelding

Complementary core strengths provide broader range of services for customers KENNESAW, GA, Aug. 16, 2017 (GLOBE NEWSWIRE) -- Brand Industrial Services, known as BrandSafway, has signed an agreement to acquire Venko Groep BV, a portfolio company of Mentha Capital. Venko will become a part of the Brand Energy & Infrastructure Services (Brand) group. "We are very pleased to announce the agreement with Venko," said Bill Hayes, President and CEO of BrandSafway. "Our combined customers in Europe will benefit from a broader range of solutions and greater depth of expertise in access, insulation and coatings. Bringing Venko's highly specialized knowledge in coatings to BrandSafway will provide the expertise we need to expand our services in the offshore market worldwide." Based in the Netherlands, with a focus on operations in the North Sea area, Venko is a leading offshore and onshore coatings maintenance provid

I vårt presserom finner du alle våre siste saker, kontaktpersoner, bilder, dokumenter og annen relevant informasjon om oss.

Besøk vårt presserom